...
首页> 外文期刊>Acta medica Iranica. >Photorefractive Keratectomy With Mitomycin-C for High Myopia: Three Year Follow-Up Results
【24h】

Photorefractive Keratectomy With Mitomycin-C for High Myopia: Three Year Follow-Up Results

机译:丝裂霉素C屈光性角膜切除术治疗高度近视的三年随访结果

获取原文

摘要

Photorefractive keratectomy (PRK) is a safe and effective surgical keratorefractive techniquewhich is done with the application of mitomycin-C (MMC) in cases of high myopia to prevent the formationof corneal haze This study was conducted to evaluate 3-year visual acuity and quality outcomes of PRKMMCin high myopia. This before-after study was conducted on 20 individuals (40 eyes) with myopia morethan 6.0 diopter (D). Visual acuity and quality indices were evaluated before and three years after theprocedure and their stability was examined between the 1st and 3rd years. At 3 years after surgery, meanuncorrected visual acuity was 0.03±0.06 in the logarithm of minimum angle of resolution (logMAR) unitwhich showed a significant improvement when compared to baseline (P<0.001) and means best correctedvisual acuity was 0.03±0.06 logMAR, which showed no significant difference (P=0.730). Manifest refractionspherical equivalent (MRSE) at 3 years (-0.12±0.2D) was significantly decreased when compared to baseline(P<0.001), but it did not change significantly after the 1st year and was stable (P=0.368). Mean coma andspherical aberration 3 years postoperatively were -0.54±0.26 μm and 0.46±0.19 μm, respectively, and neitherparameter showed significant differences when compared to baseline (P<0.001). No significant change wasfound in mesopic contrast sensitivity. The long-term results of this study showed that PRK-MMC could beregarded an effective, safe, and stable procedure in patients with myopia more than 6.0 D.
机译:光折射性角膜切除术(PRK)是一种安全有效的手术角膜屈光术,在高度近视的情况下应用丝裂霉素C(MMC)可以防止角膜混浊的形成。本研究旨在评估3年视力和质量结果PRKMMC在高度近视中的作用。这项前后研究针对近视度数超过6.0屈光度(D)的20位个体(40眼)进行。在手术前和手术后三年评估视敏度和质量指数,并在第一和第三年之间检查其稳定性。术后3年,最小分辨角(logMAR)单位的对数平均矫正视力为0.03±0.06,与基线相比有显着改善(P <0.001),意味着最佳矫正视力为0.03±0.06 logMAR。差异无统计学意义(P = 0.730)。与基线相比,3年时(-0.12±0.2D)的明显屈光度当量(MRSE)显着降低(P <0.001),但在第1年后没有明显改变,并且保持稳定(P = 0.368)。术后3年的平均昏迷和球差分别为-0.54±0.26μm和0.46±0.19μm,并且与基线相比,两个参数均无显着差异(P <0.001)。中观对比敏感度未发现明显变化。这项研究的长期结果表明,对于超过6.0 D的近视患者,PRK-MMC可被视为一种有效,安全和稳定的手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号